Current Psychopharmacology
Title:Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine
Volume: 6
Author(s): Andrea R. Durrant and Uriel Heresco-Levy
Affiliation:
Export Options
About this article
Cite this article as:
Durrant R. Andrea and Heresco-Levy Uriel , Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine, Current Psychopharmacology 2017; 6 (2) . https://dx.doi.org/10.2174/221155600602180102105314
DOI https://dx.doi.org/10.2174/221155600602180102105314 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis
Current Medicinal Chemistry Prospects for miR-21 as a Target in the Treatment of Lung Diseases
Current Pharmaceutical Design Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Studies of Substituted 1, 2, 3, 4- Tetrahydro Pyrimidine Phosphorus Derivatives
Combinatorial Chemistry & High Throughput Screening The Contrasting Roles of NKT Cells in Tumor Immunity
Current Molecular Medicine Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders
CNS & Neurological Disorders - Drug Targets St. Johns Wort Components and the Brain: Uptake, Concentrations Reached and the Mechanisms Underlying Pharmacological Effects
Current Drug Metabolism Biological Properties of Heterocyclic Pyridinylimines and Pyridinylhydrazones
Letters in Drug Design & Discovery Characterization of Mitogen-Activated Protein Kinase Expression in Nucleus Accumbens and Hippocampus of Rats Subjected to Food Selection in the Cafeteria Diet Protocol
CNS & Neurological Disorders - Drug Targets Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer’s Disease? Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry An Overview of Recent Patents on Oral Osmotic Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)
Current Pharmaceutical Design MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Differences in Corticomotor Excitability Between Hemispheres Following Performance of a Novel Motor Training Task
Neuroscience and Biomedical Engineering (Discontinued) Assessing Depression in Patients with an Acute Coronary Syndrome: A Literature Review
Current Psychiatry Reviews Meet Our Editorial Board Member
Current Pharmacogenomics and Personalized Medicine Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Raman Spectroscopy as a Novel Technology in Forensic Toxicological Analyses
Current Analytical Chemistry Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease
Current Alzheimer Research Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Current Pharmaceutical Design